Post by Sterling Cooley

Bioelectronic medicine is moving from theory to clinical reality. New data confirms that non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) significantly suppresses systemic inflammation. A randomized, sham-controlled trial of 32 hospitalized patients with elevated biomarkers (CRP >40 mg/L) utilized a 60-minute daily taVNS protocol. The results were definitive. Active stimulation reduced C-reactive protein (CRP) by 52%, IL-6 by 41%, and TNF-α by 37%. Heart rate variability (RMSSD) increased by 28%, confirming successful parasympathetic activation. The mechanism relies on the cholinergic anti-inflammatory pathway. Vagal signals trigger the splenic nerve to release acetylcholine, which binds to α7nAChR on macrophages, inhibiting NF-κB and cytokine release. This "neural dimmer switch" provides a safe, drug-free method to modulate immune responses in sepsis and autoimmune conditions. https://lnkd.in/gd-_aN37